Abstract
Introduction
Reports indic ate that reconstru ction of the oss icular chain is necessary in 40 to 90% of all tymp anoplasty proc edures. \ Closure of the air-bone ga p to less than 20 dB occurs in 40 to 70% of pat ient s who have an intact stapes and in 20 to 55% of those whose stapes supra stru cture is missing.i-'
A wide variety of ossic uloplasty techniques and material s have been develop ed since Wull stein introdu ced passive impl antable pro sthe ses in 1952: Th e most commonly used reconstru ction mat erials are aut ografts, homo grafts, and synthetic prosth eses made of plastic pore, gold,5-6 cerami c"!' and, most recen tly, titanium .P" Despite the variety of prosth esis mate rials, only limited information is available on surgeons' preferen ces for each. In clinic al practice, surgeons base their choice of material on the surgical-h andlin g characteristics of the different pro stheses, as we ll as on aud iom etric performance dat a. With respect to surgical-handling attri butes, the ideal pro sth esis would be easy to use, biocornpatible, and versatile enough to allow for adaptation in indiv idua l cases.Agood prosthesis should also remain in plac e and stable ove r the long term.
In addition to the typ e of materi al used, the design of a prosthesi s also influenc es its surg ica l-hand ling prop erties, the most important of which pertain to visual control , positionin g, and co upling .
The late st step in the effort to achieve th e ideal prosthesis was the developm ent of the open titanium prosthesis. Its audio metric performance was previously shown to be at least equal to that of the other materials used for oss icular reco nstrution." To date, no data have been publi shed on the intraop erative ergo nomic properti es of titan ium prostheses. Thi s lack of information led us to conduct a study of surgeo ns' opinions regarding their use of the titanium prosthesis. We also asked surgeo ns to comp are their experience with the titanium impl ant w ith thei r previous experience in using go ld, ceramic, and autograft implants.
Subjects, materials, and methods
Surgeons. Ou r study was based on questionn aire responses provid ed by 32 otologic surgeons who used the open T ubinge n titanium prosthesis for primary and revi-
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sion oss iculoplasty during tymp anoplasty in 400 patients at 12 academic and nonacademic otolaryngo logy clinic s, mo st of them in Germ any. Th ese surgeons performed both partial ossi cular replaceme nt prost hesis (PORP) and total ossicul ar rep lacement prosthesis (TORP) procedures .
To be eligible to parti cipate in the survey, surgeo ns were required to have had experience in placing titanium, go ld, ceramic, and autograft ossicular implants. No restrictions were placed on indiv idua l surg ical techniques used to recons tructthe tympan ic membrane.All proce dures had been performed betwee n Jan. 15, 1998, and Dec. 23, 1999 .
Patients. The selec tion of patients whose cases were includ ed in this study was based on seve ral crit eria. Patient s were required to be 18 years of age or older and of sound mind . They had to have had a lesion on at least part of the incu s and/or a missing stapes suprastructure. Th e presenc e or abse nce of the malleus handl e was not taken into consideration.
Eac h patient received only one imp lant during the stud y. To guard against systematic se lection bias , we studie d the cases of consec utively presenting patie nts who met the eligibility cr iteria .
. Questionnaire. Th e participa ting surgeo ns we re aske d to compl ete the questionnair e as soo n as possible afte r each opera tion. Th e three main sec tions of the survey conce rned the patient 's clinical status, the preparation of the ossicular imp lant, and the handl ing of the implant during the operation.
Clinical status. Th ese questions concerned the patient's history of surgery on the affected ear and the condition of the ear wit h respect to otor rhea , inflammat ion, etc.
Preparation. Surgeons were asked abo ut (I) the type of operatio n (partial or total), (2) the amount of tim e requ ired to prepare the titanium impl ant for placement, (3) the typ e of implant material (go ld, ceram ic, or autograft) they used before the titan ium imp lant became ava ilable, (4) the ir opinion of the efficacy of the alterna tives , and (5) their estimation, based on the ir expe rience , as to how much preparation would have been required to use an alternative implant.
Intraop erative handling. Most ofthis part ofthe questionnaire asked physic ians to rate vario us aspects of placing titani um and alternative implant s on a scale of I (a favorable ratin g) to 7 (unfavo rab le). Th ese ratings conc erned issues such as the surgeon s' ability to secure placement immed iately without the need to modi fy the impl ant' s length and the time required to modify the imp lant if the initia l attem pt at place ment failed . Surgeons were also aske d to rate thei r overall impression of the intrao perative handl ing characteristics of all the types of impla nts , taking into consideration factors such as positioning, length adj ustme nt, the degree ofvisibility ofthe stapes head (with the PORP) or footplate (w ith the TORP), and the stabi lity of the co upling. 
Prostheses. The part icular titanium prosthesis used in this

Results
Patients.
The 400 patients who underwent surgery include d 230 men and 166 wo men (the sex of 4 patients was not record ed). Enough data were miss ing from 17 questionnair es to disqu alify them from the statistical analys is. Of the rem ainin g 383 opera tions, 2 16 (56 .4% ) were revision proced ures and 167 (43 .6%) we re primary procedures.
Preoperatively, the midd le ear was dry in 196 patient s (5 1.2%), while 184 patients (48 .0%) had acute exacerbations of chron ic otitis media; information on the clin ica l status on patients was not reco rded . The tympanic mernbranewas intact in 115 patients (30 .0%); 78 patients (20.4 %) had a sma ll defect, 12 1 (3 1.6%) had a mid size defect , 50 ( 13. 1%) had a subtotal defect, and 18 (4.7%) had a tota l defect. Information on I patient was missing.
Type of operation. Of the 383 pati ents , 256 (66.8%) received a PORP and 127 (33.2%) received a TORP.
Length of implant. Surgeo ns ge nera lly preferred the 2.0 -, 2.25 -, and 2.5-mm titani um PORP and the 4 .0-m m TORP ( figure I) .
Choice ofalternatives. If a titanium prosthesis had not bee n available, surgeons would have used a gold prosthesis in 248 cases (64.7 %), the head of the ma lleus in 58 cases (15.1%), ceramic in45 cases ( 11.7%), the incus in 29 cases (7.6%), and an unspecified material in 3 cases (0.8%).
Preparation of the pro sthesis . O f 387 operations for '
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which preparation data were avai lable , the Ttibi ngen titanium prosthesis was taken directly from the package and used without the need for mod ification prior to implantation in 365 cases (94 .3%). Most ofthe modifications in the remaini ng 22 cases invol ved simply bend ing the device to change the ang le between the shaft and the ope n platform . By contras t, the 174 questionnaires that includ ed information on the preparation of ceramic prost heses indicated that modification would have been necessary in 129 cases (74. 1%) and unn ecessary in only 45 (25.9 %). On 136 questionnaires, surgeons prov ided informatio n on the length of time it has take n them to reshape a nonm etal (cera mic or autograft) implant before placement in similar situations. Th e length oftime in these cases ranged from 2 minut es up to 30 minu tes in a single unr epresentative case (med ian: 5). Half of these mod ifications took between 3 and 10 minutes. Th e amount of time req uired to mod ify a metal (titanium or go ld) pros thesis when necessary was significantly (p < 0.00 I) shorter.
Intraop erative handling. Eva 
ORT Discussion
Desp ite the introduction of new designs for middle ear prostheses durin g the past 40 years, no single devic e has emerged as the un iformly accep ted standard. For this and other reasons, ossic uloplasty remains an unreliable procedure. Nevertheless, we be lieve that a comparison of the different types of prostheses and their particular intraoperative handling characteristics might lead to further improvement in prosthesis design and perhaps in the results of ossiculoplasty itself. This belief provided the impetus for our study.
We focused our attention on the intraoperative handl ing characteristics of the titan ium prost hesis as assessed prospective ly by surgeo ns dur ing the immediate postoperative period. We compared these findin gs with the surgeo ns' retrosp ect ive assess ments (based on their experience) of gold, ceramic, and autogra ft implants. The followingtreatment-related adverse eventswere each reported10 a slOgIe patient: tympanostomytube blockage; ear pruritus; tinnitus; oral monilias is; crying; dizziness; and erythema. Acute Otitis Externa: The foll owing treatment-relatedadverse events occurred in0.4%or more ofthe patients with intacttympanicmembranes.
The following treatment-related adverseeventswere each reported in a single patient:ear discomfort; decreased hearing; and ear disorder (tingling).
DOSAGE ANDADMINISTRATION CIPRODEX' OTIC SHOULD BESHAKEN WEll IMMEDIATELY BEFORE USE CIPRODEX' Oti c contains3 mg/mL (3000~g / m L ) ciprofloxac in and 1 mg/mL dexamethasone.
Acute Otitis Media in pediatric patients with tympanostomytubes: The recommended dosage regim en for the treatment ofacute otitismedia inpediatric patients(age 6 monthsand older)throughtym panostomytubes is: Four drops(0.14 ml , 0.42mg ciprofloxacin, 0.14 mgdexamethasone) instilled into the affectedear twice daily for seven days. The solution shoul d be warmed by holdin g the bottle in the hand for one or two minutes to avoid dizziness.
which may result from the instillation of a cold sol ution. The patient should lie with the affectedear upward,and then the dropsshould be instilled. The tragus should thenbe pumped 5 times by pushing inward to facilitate penetration of the dropsinto the middle ear . This position should be maintained for 60seconds. Repeat, if necessary, for the opposite ear. Discard unused portion aftertherapyis completed. Acute Oti tis Externa: The recommended dosage regimenfort hetreatment of acute otitis externais: For patients (age6 months and older):Four drops (0.14 mL, 0.42mgciprofloxaci n, 0.14mg dexamethasone) instilled into the affected ear twice daily for seven days. The solution should be warmed byholding the bottle in the handfor one or two minutesto avoid dizziness, which may resultfromtheinstillation of a coldsolution. The patient should liewiththe affectedear upward,andthenthedrops should beinstilled. This positionshould bemaintained for 60 secondsto facilitatepenetration of the dropsinto the ear canal.Repeat, ifnecessary, forthe oppositeear. Discard unused portio n after therapyis completed.
Pregnancy Teratogenic Effects. Pregnancy Category C: Reproduction studies have been performed in rats and mice using oral doses of upto 100 mg/kg and IV doses upto 30 mg/kg andhaverevealed no evidence of harm to thefetus as a result of ciprofloxacin. ln rabbits, ciprofloxacin (3Dand100 mg/kg orally) produced gastrointestinal disturbances result ingin maternal weight loss and an increased incidence of abortion, but no teratogenic itywas observed at eitherdose. After intraveno us administration of doses up to 20 mg/kg, no maternal toxicitywas produced in the rabbit, and no embryotoxicityor teratogenicitywas observed. Corticosteroids are generally teratogenicin laboratoryanima lswhenadministeredsystemicallyat relativelylowdosagelevels. clinical cures in 81% and 94% of per protocol evaluable AOE patients, respectively, compared to 84% and 89%, respectively, for otic suspension containing neomycin0.35%,polymyxi n B10,000IU/mL, and hydroco rtisone 1. 0%
(neo/poly/HC). Among culture positive patients clinical cureswere 86%and 92% for CIPROD EX' Otic comparedto 84% and89%, respectively,for neo/poly /HC. Microbiological eradication rates forthese patients inthe same clinical trials were 86% and92% for CIPRODE X' Otic compared to 85%and85%,respectively,for neo/poly/HC.
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1.CIPRDDEX' Otic package insert. urable plasma concentrations of ciprofloxa cin and dexamethasone were observed at 6 hours foll owing admi nistrationin 2 of9 patients and 5 of 9 patients, respectively.
2.Roland PS
Mean ± SOpeak plasma concentrations of ciprofloxaci n were 1.39 ± 0. 880ng/ml (n=9) . Peak plasma concentrationsrangedfrom0.543 ng/ml to 3.45ng/ml and were on averageapproximately 0.1%of peak plasma concentra- reported in patients receivin g systemi c qui nolones. Serious acute hypersensitivi ty reactions may require immediate emergencytreatment.
PRECAUTIONS
General: As with other antibacterial preparations, use ofthis product may resultin overgrowthof nonsusceptible organisms, includingyeast and fungi. Ifthe infection is not improved after one weekof treatment, cultures should be obtained to guide furth er treatment. If otorrhea persists after a fullcourse oftherapy, or iftwoor moreepisodes of otorrhea occur withinsixmonths, further evaluation is recomm ended to excludean underlying condition such as cholesteatoma, foreign body, or a tumor. The systemic administration of quinolones, including ciprofloxacin at doses much higher than given or absorbed by the otic route, has led to lesions or erosions of the cartilage in weight -bearingjoints andother signs of arthropathyinimma ture animals ofvarious species.Guinea pigsdosed in wouldbe over 100 times the maximum recommended clinical dose of ototopical ciprofl oxaci n based upon body surface area,assumi ng total absorption of ciprofloxaci n from the ear of a patient treated with CIPRDDEX' Otic twice per day accordingto label directions. Longtermstudies have not been performed to evaluate the carcinogenic potential oftopical otic dexamethasone. Dexamethasone has been tested for in vitro and in vivo genotoxic potential and shownto be positive inthe followingassays; chromosomal aberrations, sister-chromat idexchange in human lymphocytes and micronuclei and sister-chromatid exchanges in mouse bone marrow. However, the Ames/Salmonelia assay, both with and without S9mi x, did not show anyincrease in His-revertants. The effectof dexamethasone onfertility has not been investigated followingtopical otic appl ication. However, the lowest toxi c doseof dexamethasoneidentified followingtopical dermal application was 1. 802mg/kgin a26-week studyinmale rats and resulted in changesto the testes, epididymi s, spermduct, prostate, semina lvessicle,Cowper's glandand accessory glands. The relevance ofthis studyfor shorttermtopical otic use is unknown. Figure 2 . experience andj udg ment. Only 6% ofthe surgeo ns surveyed by Go lde nberg and Emmet indicated that they used a sizer to determine the length ofa prosthesis before implantation." Some prostheses are designed so that surgeons have the option ofclearly seeing both contact points simultaneously. Good vis ibi lity may con tribute to good coup ling. Th e specific des ign of a pros thes is has an effec t on the surgeon's abi lity to see the surgica l fie ld dur ing positioning. Design features that improve visi bility include a slim axis, a sma ll foot, and an open head . Th e latter is a particular design attrib ute of the T ubingen impl ant but Because a study of the audiometric benefits of titanium prostheses was recently reported by Ze nner et al," we did not invest igate this partic ular param eter. In 200 I , Go ldenbe rg and Emmet published the res ults of their survey of members of the American O tologica l Society and the American Neurotology Society regard ing their use ofm idd le ear implants.31They found that although only 12% of respondents performed such surgery , their satisfaction with titanium implants was extraordinary (satisfaction rate : 100%) . This approval may be attributable in part to the excellent intraoperative handling characteristics dem onstrated in our study.
SURGICAL-HANDLING PROPERTIES OF THE TITANIUM PROSTHESIS IN OSSICULOPLASTY
Because metal prosth eses are ava ilable in a w ide va riety oflengths (unlike non metal pro sth eses), sig nifica ntly less tim e was required to prepare them for impl ant ation. O ur finding that surgeons preferred the 2.0-, 2.25-, and 2.5-mm titanium prostheses for PO RP and the 4.0 -m m device for TO RP is consistent with the results of a study by Stupp et "al,1\ who conducted a retrospective multicenter study of the nearly closed Dusseldorf titanium prosthesis (Kurz) in 66 I patients.
The weight of the diffe rent prostheses varies. Ceramic units are the heaviest, ran ging fro m 29 .8 to 35 .7 mg. Go ld implants weigh between 28 .0 and 4 0.2 mg, and titani um devices are the light est, we ighing between 4. I and 10.1 mg. T he greater weight ofthe ceramic and go ld prostheses may have a more unfavorable effect on the ir acoustic properties. The titanium prostheses weigh approximately the sa me amount as do stapes ossicles. The more a prosthesis weighs, the more diffic ult it is to manipu late intraoperative ly and the more likely it is to tilt dur ing and after placement. T he ligh ter a prosthesis is, the better it adheres to blood , whic h makes han dling easier. Less we ight also faci litates fine readjustm ents dur ing positioning.
Th e process of adj usting the len gth of a pros thesis to achieve the appropriate amount of tension an d establish proper co nd uction is pr imari ly a functio n of a surgeon's The fact that the surgeons in our study indicated that the coupling characteristics and stability of the titanium imp lant in the eard rum and stapes were sup erior to that of the others may also be attributable to desi gn features that allow for sim ultaneou s visualization ofboth contact points during both PORP and TOR P procedures. The struct ure of cera m ic and autograft imp lants, on the other hand , ca n block the surgeo n's vis ion ofthe co upling site and thereby have a negative impac t on the reliability of the coupling process. Visibility with go ld imp lants is better than that with cerami c and auto graft implants, but it is not as good as visibility with titanium prosth eses.
In conclusion, our survey show ed that the intraoperative handling charac teristics ofthe Tubingen titan ium prosthesis are superior to those of the go ld, ceramic, and autograft impl ants ; the surgeons' preferenc e for them is not simply attributable to the ir fam iliarity w ith th is type of impla nt. If futur e long-term stud ies confirm this degre e ofsatisfaction with titan ium and if acoustic outcomes remain favorabl e, titaniu m may become a preferred mate ria l for performing both total and partial ossic ulop lasties . Fina lly, consi deri ng that bone autografts req uire so much operating-roo m time to prepare, the choice of ready-to-use titanium imp lants may prove to be no less cost-effective. 
